Jenburkt Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 358.52 million compared to INR 355.08 million a year ago. Revenue was INR 371.14 million compared to INR 366.99 million a year ago. Net income was INR 68.56 million compared to INR 79.7 million a year ago. Basic earnings per share from continuing operations was INR 14.96 compared to INR 17.37 a year ago.
For the six months, sales was INR 669.84 million compared to INR 626.88 million a year ago. Revenue was INR 693.88 million compared to INR 650.74 million a year ago. Net income was INR 128.19 million compared to INR 126.21 million a year ago. Basic earnings per share from continuing operations was INR 27.93 compared to INR 27.5 a year ago.